Intuitive Surgical surges on next-gen da Vinci approval
This article was originally published in Clinica
Executive Summary
April Fool’s Day brought some cheer to Intuitive Surgical, when the company saw its share price jumped on news that the US FDA has given the green light to its next-generation surgical robotic system, da Vinci Xi.